Topical Aprepitant in Prurigo Patients An Exploratory Phase IIa Trial With Topically Applied Aprepitant in Patients With Prurigo

Trial Profile

Topical Aprepitant in Prurigo Patients An Exploratory Phase IIa Trial With Topically Applied Aprepitant in Patients With Prurigo

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Oct 2014

At a glance

  • Drugs Aprepitant (Primary)
  • Indications Prurigo; Prurigo nodularis
  • Focus Therapeutic Use
  • Acronyms iTAPP
  • Sponsors LEO Pharma
  • Most Recent Events

    • 06 Oct 2014 Status changed from recruiting to completed according to ClinicalTrials.gov record.
    • 13 Nov 2013 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov.
    • 06 Nov 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top